Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

bioAffinity Technologies (BIAF) Depreciation Expense: 2022-2025

Historic Depreciation Expense for bioAffinity Technologies (BIAF) over the last 3 years, with Sep 2025 value amounting to $44,599.

  • bioAffinity Technologies' Depreciation Expense rose 10.20% to $44,599 in Q3 2025 from the same period last year, while for Sep 2025 it was $175,636, marking a year-over-year decrease of 38.55%. This contributed to the annual value of $162,332 for FY2024, which is 30.35% down from last year.
  • As of Q3 2025, bioAffinity Technologies' Depreciation Expense stood at $44,599, which was up 0.29% from $44,468 recorded in Q2 2025.
  • Over the past 5 years, bioAffinity Technologies' Depreciation Expense peaked at $166,284 during Q4 2023, and registered a low of $800 during Q3 2022.
  • Its 3-year average for Depreciation Expense is $49,930, with a median of $42,806 in 2024.
  • In the last 5 years, bioAffinity Technologies' Depreciation Expense surged by 5,536.88% in 2023 and then plummeted by 74.26% in 2024.
  • bioAffinity Technologies' Depreciation Expense (Quarterly) stood at $7,282 in 2022, then skyrocketed by 2,183.49% to $166,284 in 2023, then tumbled by 74.26% to $42,806 in 2024, then rose by 10.20% to $44,599 in 2025.
  • Its Depreciation Expense was $44,599 in Q3 2025, compared to $44,468 in Q2 2025 and $43,763 in Q1 2025.